バイオフィルム治療市場レポート：2030年までの動向、予測、競合分析

バイオフィルム治療の動向と予測

世界のバイオフィルム治療市場は、2024年から2030年までのCAGRが7.2%で、2030年までに推定20億米ドルに達すると予測されます。この市場の主な促進要因は、慢性創傷の増加、ヘルスケア関連感染症の流行、低侵襲治療に対する需要の高まりです。世界のバイオフィルム治療市場の将来は、病院、ASC、創傷治療センター、在宅ケア市場において機会があり、有望視されています。

バイオフィルム治療市場の洞察

Lucintelは、ガーゼとドレッシングはバイオフィルムを根絶、停止、制御する能力があるため、予測期間中も最大セグメントであり続けると予測しています。

この市場において、病院、医療施設、創傷治療センターは、高齢化人口の急増と加齢関連疾患の有病率の増加により、最大セグメントであり続けると思われます。

北米は、慢性創傷の急増、高いヘルスケアコスト、同地域の主要市場プレイヤーの存在により、予測期間中も最大地域であり続けると思われます。

よくある質問

Q1.市場規模は？

A1.バイオフィルム治療の世界市場は、2030年までに推定20億米ドルに達すると予想されています。

Q2.市場の成長予測は？

A2.バイオフィルム治療の世界市場は、2024年から2030年にかけてCAGR 7.2%で成長すると予測されます。

Q3.市場の成長に影響を与える主な促進要因は？

A3.この市場の主な促進要因は、慢性創傷の発生率の増加、ヘルスケア関連感染の有病率の上昇、低侵襲治療に対する需要の高まりです。

Q4.市場の主要セグメントは？

A4.バイオフィルム治療市場の将来は、病院、ASCs、創傷ケアセンター、在宅ケアの各市場における機会が有望です。

Q5.市場の主要企業は？

A5.バイオフィルム治療の主要企業は以下の通りです。

• Smith & Nephew
• MiMedx
• ConvaTec
• Coloplast A/S
• Molnlycke Healthcare
• Organogenesis
• Integra LifeSciences
• B. Braun Melsungen
• PAUL HARTMANN
• Medline Industries

Q6.今後、最大となる市場セグメントは？

A6.Lucintelは、ガーゼとドレッシングはバイオフィルムを根絶、停止、制御する能力があるため、予測期間中最大のセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は？

A7.北米は、慢性創傷の急増、高いヘルスケアコスト、主要市場プレイヤーの存在により、予測期間中も最大地域であり続ける。

Q8.レポートのカスタマイズは可能？

A8.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界のバイオフィルム治療市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年～2030年の市場動向と予測分析

• マクロ経済動向（2018年～2023年）と予測（2024年～2030年）
• 世界のバイオフィルム治療市場動向（2018年～2023年）と予測（2024年～2030年）
• 世界のバイオフィルム治療市場、製品別
  • デブリードマン装置
  • ガーゼと包帯
  • ジェル、軟膏、スプレー
  • グラフトとマトリックス
  • ワイプ、パッド、洗浄液
• 世界のバイオフィルム治療市場、創傷タイプ別
  • 外傷および外科的創傷
  • 糖尿病性足潰瘍
  • 褥瘡
  • 静脈性脚潰瘍
  • やけど
  • その他
• 世界のバイオフィルム治療市場、用途別
  • 病院、ASC、創傷ケアセンター
  • ホームケア設定
  • その他

第4章 2018年～2030年の地域別の市場動向と予測分析

• 地域別の世界のバイオフィルム治療市場
• 北米のバイオフィルム治療市場
• 欧州のバイオフィルム治療市場
• アジア太平洋のバイオフィルム治療市場
• その他地域のバイオフィルム治療市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 製品別の世界のバイオフィルム治療市場の成長機会
  • 創傷タイプ別の世界のバイオフィルム治療市場の成長機会
  • 用途別の世界のバイオフィルム治療市場の成長機会
  • 地域別の世界のバイオフィルム治療市場の成長機会
• 世界のバイオフィルム治療市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のバイオフィルム治療市場の能力拡大
  • 世界のバイオフィルム治療市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Smith & Nephew
• MiMedx
• ConvaTec
• Coloplast A/S
• Molnlycke Healthcare
• Organogenesis
• Integra LifeSciences
• B. Braun Melsungen
• PAUL HARTMANN
• Medline Industries

Biofilm Treatment Trends and Forecast

The future of the global biofilm treatment market looks promising with opportunities in the hospital, ASCs, & wound care center and home care setting markets. The global biofilm treatment market is expected to reach an estimated $2 billion by 2030 with a CAGR of 7.2% from 2024 to 2030. The major drivers for this market are increasing incidence of chronic wounds, rising prevalence of healthcare-associated infections, and growing demand for minimally invasive therapies.

A more than 150-page report is developed to help in your business decisions.

Biofilm Treatment by Segment

The study includes a forecast for the global biofilm treatment by product, wound type, application, and region.

Biofilm Treatment Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Debridement Equipments
• Gauzes & Dressings
• Gels, Ointments, & Sprays
• Grafts & Matrices
• Wipes, Pads, & Lavage Solutions

Biofilm Treatment Market by Wound Type [Shipment Analysis by Value from 2018 to 2030]:

• Traumatic & Surgical Wounds
• Diabetic Foot Ulcers
• Pressure Ulcers
• Venous Leg Ulcers
• Burns
• Others

Biofilm Treatment Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals, ASCs, & Wound Care Centers
• Home Care Settings
• Others

Biofilm Treatment Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Biofilm Treatment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies biofilm treatment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biofilm treatment companies profiled in this report include-

• Smith & Nephew
• MiMedx
• ConvaTec
• Coloplast A/S
• Molnlycke Healthcare
• Organogenesis
• Integra LifeSciences
• B. Braun Melsungen
• PAUL HARTMANN
• Medline Industries

Biofilm Treatment Market Insights

Lucintel forecasts that gauze & dressing will remain the largest segment over the forecast period due to its capacity to eradicate, stop, and control biofilms.

Within this market, hospital, asc, & wound care center will remain the largest segment due to surge in aging population as well as growth in prevalence of age-related diseases.

North America will remain the largest region over the forecast period due to surge in the prevalence of chronic wounds, high healthcare costs, and the presence of major market players in this region.

Features of the Global Biofilm Treatment Market

Market Size Estimates: Biofilm treatment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Biofilm treatment market size by product, wound type, application, and region in terms of value ($B).

Regional Analysis: Biofilm treatment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, wound types, applications, and regions for the biofilm treatment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biofilm treatment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the biofilm treatment market size?

Answer: The global biofilm treatment market is expected to reach an estimated $2 billion by 2030.

Q2. What is the growth forecast for biofilm treatment market?

Answer: The global biofilm treatment market is expected to grow with a CAGR of 7.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the biofilm treatment market?

Answer: The major drivers for this market are increasing incidence of chronic wounds, rising prevalence of healthcare-associated infections and growing demand for minimally invasive therapies.

Q4. What are the major segments for biofilm treatment market?

Answer: The future of the biofilm treatment market looks promising with opportunities in the hospital, ASCs, & wound care center and home care setting markets.

Q5. Who are the key biofilm treatment market companies?

Answer: Some of the key biofilm treatment companies are as follows.

• Smith & Nephew
• MiMedx
• ConvaTec
• Coloplast A/S
• Molnlycke Healthcare
• Organogenesis
• Integra LifeSciences
• B. Braun Melsungen
• PAUL HARTMANN
• Medline Industries

Q6. Which biofilm treatment market segment will be the largest in future?

Answer: Lucintel forecasts that gauze & dressing will remain the largest segment over the forecast period due to its capacity to eradicate, stop, and control biofilms.

Q7. In biofilm treatment market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to surge in the prevalence of chronic wounds, high healthcare costs, and the presence of major market players in this region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the biofilm treatment market by product (debridement equipments, gauzes & dressings, gels, ointments, & sprays, grafts & matrices, and wipes, pads, & lavage solutions), wound type (traumatic & surgical wounds, diabetic foot ulcers, pressure ulcers, venous leg ulcers, burns, and others), application (hospitals, ASCs, & wound care centers, home care settings, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biofilm Treatment Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Biofilm Treatment Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Biofilm Treatment Market by Product
  • 3.3.1: Debridement Equipments
  • 3.3.2: Gauzes & Dressings
  • 3.3.3: Gels, Ointments, & Sprays
  • 3.3.4: Grafts & Matrices
  • 3.3.5: Wipes, Pads, & Lavage Solutions
• 3.4: Global Biofilm Treatment Market by Wound Type
  • 3.4.1: Traumatic & Surgical Wounds
  • 3.4.2: Diabetic Foot Ulcers
  • 3.4.3: Pressure Ulcers
  • 3.4.4: Venous Leg Ulcers
  • 3.4.5: Burns
  • 3.4.6: Others
• 3.5: Global Biofilm Treatment Market by Application
  • 3.5.1: Hospitals, ASCs, & Wound Care Centers
  • 3.5.2: Home Care Settings
  • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Biofilm Treatment Market by Region
• 4.2: North American Biofilm Treatment Market
  • 4.2.2: North American Biofilm Treatment Market by Application: Hospitals, ASCs, & Wound Care Centers, Home Care Settings, and Others
• 4.3: European Biofilm Treatment Market
  • 4.3.1: European Biofilm Treatment Market by Product: Debridement Equipment, Gauzes & Dressings, Gels, Ointments, & Sprays, Grafts & Matrices, and Wipes, Pads, & Lavage Solutions
  • 4.3.2: European Biofilm Treatment Market by Application: Hospitals, ASCs, & Wound Care Centers, Home Care Settings, and Others
• 4.4: APAC Biofilm Treatment Market
  • 4.4.1: APAC Biofilm Treatment Market by Product: Debridement Equipment, Gauzes & Dressings, Gels, Ointments, & Sprays, Grafts & Matrices, and Wipes, Pads, & Lavage Solutions
  • 4.4.2: APAC Biofilm Treatment Market by Application: Hospitals, ASCs, & Wound Care Centers, Home Care Settings, and Others
• 4.5: ROW Biofilm Treatment Market
  • 4.5.1: ROW Biofilm Treatment Market by Product: Debridement Equipment, Gauzes & Dressings, Gels, Ointments, & Sprays, Grafts & Matrices, and Wipes, Pads, & Lavage Solutions
  • 4.5.2: ROW Biofilm Treatment Market by Application: Hospitals, ASCs, & Wound Care Centers, Home Care Settings, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Biofilm Treatment Market by Product
  • 6.1.2: Growth Opportunities for the Global Biofilm Treatment Market by Wound Type
  • 6.1.3: Growth Opportunities for the Global Biofilm Treatment Market by Application
  • 6.1.4: Growth Opportunities for the Global Biofilm Treatment Market by Region
• 6.2: Emerging Trends in the Global Biofilm Treatment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Biofilm Treatment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biofilm Treatment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Smith & Nephew
• 7.2: MiMedx
• 7.3: ConvaTec
• 7.4: Coloplast A/S
• 7.5: Molnlycke Healthcare
• 7.6: Organogenesis
• 7.7: Integra LifeSciences
• 7.8: B. Braun Melsungen
• 7.9: PAUL HARTMANN
• 7.10: Medline Industries